Fig. 10From: Multifunctional nanocomposites DDMplusAF inhibit the proliferation and enhance the radiotherapy of breast cancer cells via modulating tumor-promoting factors and metabolic reprogrammingGraphical summary. This graphical representation illustrates the modulatory effect of DDMPlusAF in combination with radiotherapy on BCCs through its components as 2DG (hexokinase inhibitor), DCA (PDK inhibitor), and amygdalin associated with exposure to 6Â Gy-FDRBack to article page